Allianz Asset Management GmbH Purchases 70,715 Shares of Rollins, Inc. $ROL

Allianz Asset Management GmbH grew its holdings in shares of Rollins, Inc. (NYSE:ROL) by 181.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 109,715 shares of the business services provider’s stock after acquiring an additional 70,715 shares during the period. Allianz Asset Management GmbH’s holdings in Rollins were worth $6,190,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in ROL. AMF Tjanstepension AB grew its stake in Rollins by 196.2% during the second quarter. AMF Tjanstepension AB now owns 3,542,898 shares of the business services provider’s stock worth $199,937,000 after purchasing an additional 2,346,592 shares during the period. Zurich Insurance Group Ltd FI bought a new position in shares of Rollins during the 1st quarter worth approximately $59,073,000. Nuveen LLC acquired a new stake in shares of Rollins during the 1st quarter worth approximately $54,685,000. Vanguard Group Inc. increased its stake in shares of Rollins by 3.0% in the 1st quarter. Vanguard Group Inc. now owns 34,736,543 shares of the business services provider’s stock valued at $1,876,815,000 after acquiring an additional 999,797 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. bought a new stake in shares of Rollins in the 1st quarter valued at $50,547,000. 51.79% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ROL. Weiss Ratings reissued a “buy (b)” rating on shares of Rollins in a research note on Tuesday, October 14th. Wells Fargo & Company reiterated an “overweight” rating and set a $65.00 price objective (up previously from $63.00) on shares of Rollins in a report on Wednesday, June 25th. UBS Group raised their target price on Rollins from $59.00 to $61.00 and gave the company a “neutral” rating in a research note on Friday, July 25th. JPMorgan Chase & Co. started coverage on Rollins in a research report on Friday, September 26th. They issued an “overweight” rating and a $70.00 target price for the company. Finally, Barclays increased their price target on Rollins from $55.00 to $60.00 and gave the stock an “equal weight” rating in a report on Friday, July 25th. Eight investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $62.18.

Rollins Stock Up 0.5%

Shares of NYSE ROL opened at $56.61 on Thursday. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.68 and a quick ratio of 0.63. The company has a 50-day moving average price of $56.94 and a 200-day moving average price of $56.54. The stock has a market capitalization of $27.43 billion, a P/E ratio of 56.05 and a beta of 0.69. Rollins, Inc. has a 1 year low of $45.34 and a 1 year high of $59.12.

Rollins (NYSE:ROL) last announced its quarterly earnings results on Wednesday, July 23rd. The business services provider reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.01. The business had revenue of $999.53 million for the quarter, compared to analysts’ expectations of $988.77 million. Rollins had a net margin of 13.70% and a return on equity of 36.96%. The firm’s revenue for the quarter was up 12.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.27 EPS. On average, equities research analysts forecast that Rollins, Inc. will post 1.09 EPS for the current fiscal year.

Rollins Company Profile

Rollins, Inc, through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife.